These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 11474311

  • 1. Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
    Adamek RJ, Behrendt J, Wenzel C.
    Eur J Gastroenterol Hepatol; 2001 Jul; 13(7):811-7. PubMed ID: 11474311
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
    van Zyl JH, de K Grundling H, van Rensburg CJ, Retief FJ, O'Keefe SJ, Theron I, Fischer R, Bethke T.
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):197-202. PubMed ID: 10741935
    [Abstract] [Full Text] [Related]

  • 3. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S, Dibildox M, Moguel A, Di Silvio M, Rodríguez F, Almaguer I, García C.
    Rev Gastroenterol Mex; 1998 Feb; 63(1):11-6. PubMed ID: 10068743
    [Abstract] [Full Text] [Related]

  • 4. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
    Gisbert JP, Carpio D, Marcos S, Gisbert JL, García Grávalos R, Pajares JM.
    Eur J Gastroenterol Hepatol; 2000 May; 12(5):489-95. PubMed ID: 10833090
    [Abstract] [Full Text] [Related]

  • 5. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
    Holtmann G, Cain C, Malfertheiner P.
    Gastroenterology; 1999 Jul; 117(1):11-6. PubMed ID: 10381904
    [Abstract] [Full Text] [Related]

  • 6. Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.
    Bardhan KD, Dillon J, Axon AT, Cooper BT, Tildesley G, Wyatt JI, Gatz G, Braun W.
    Aliment Pharmacol Ther; 2000 Jan; 14(1):59-67. PubMed ID: 10632646
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate.
    Meneghelli UG, Boaventura S, Moraes-Filho JP, Leitão O, Ferrari AP, Almeida JR, Magalhães AF, Castro LP, Haddad MT, Tolentino M, Jorge JL, Silva E, Maguilnik I, Fischer R.
    Dis Esophagus; 2002 Jan; 15(1):50-6. PubMed ID: 12060043
    [Abstract] [Full Text] [Related]

  • 8. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
    Dettmer A, Vogt R, Sielaff F, Lühmann R, Schneider A, Fischer R.
    Aliment Pharmacol Ther; 1998 Sep; 12(9):865-72. PubMed ID: 9768529
    [Abstract] [Full Text] [Related]

  • 9. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

  • 10. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
    Armbrecht U, Abucar A, Hameeteman W, Schneider A, Stockbrügger RW.
    Aliment Pharmacol Ther; 1997 Oct; 11(5):959-65. PubMed ID: 9354207
    [Abstract] [Full Text] [Related]

  • 11. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
    Lamouliatte H, Samoyeau R, De Mascarel A, Megraud F.
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1523-30. PubMed ID: 10571611
    [Abstract] [Full Text] [Related]

  • 12. Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis.
    Escourrou J, Deprez P, Saggioro A, Geldof H, Fischer R, Maier C.
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1481-91. PubMed ID: 10571605
    [Abstract] [Full Text] [Related]

  • 13. Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study.
    Koop H, Schepp W, Dammann HG, Schneider A, Lühmann R, Classen M.
    J Clin Gastroenterol; 1995 Apr; 20(3):192-5. PubMed ID: 7797824
    [Abstract] [Full Text] [Related]

  • 14. Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group.
    Adamek RJ, Bethke TD.
    Am J Gastroenterol; 1998 Oct; 93(10):1919-24. PubMed ID: 9772056
    [Abstract] [Full Text] [Related]

  • 15. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A, Wiseman L.
    Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up.
    Van Rensburg CJ, Honiball PJ, Van Zyl JH, Grundling HD, Eloff FP, Spies SK, Simjee AE, Theron I, Fischer R, Louw JA.
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1023-8. PubMed ID: 10468676
    [Abstract] [Full Text] [Related]

  • 17. One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux symptoms in patients with healed reflux oesophagitis.
    Mössner J, Koop H, Porst H, Wübbolding H, Schneider A, Maier C.
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1087-92. PubMed ID: 9663834
    [Abstract] [Full Text] [Related]

  • 18. Prevention of erosive oesophagitis relapse with pantoprazole.
    Richter JE, Fraga P, Mack M, Sabesin SM, Bochenek W, Pantoprazole US GERD Study Group.
    Aliment Pharmacol Ther; 2004 Sep 01; 20(5):567-75. PubMed ID: 15339328
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO, Wilcox CM, DeVault K, Miska D, Bochenek W, Pantoprozole US Gerd Study Group B.
    Aliment Pharmacol Ther; 2002 Dec 01; 16(12):2043-52. PubMed ID: 12452936
    [Abstract] [Full Text] [Related]

  • 20. Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole.
    Pilotto A, Leandro G, Franceschi M, Ageing and Acid-Related Disease Study Group.
    Aliment Pharmacol Ther; 2003 Jun 01; 17(11):1399-406. PubMed ID: 12786634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.